A collaboration of stakeholders in the public and private sectors across sub-Saharan Africa (SSA) launched the Coalition of Blood for Africa (CoBA) on a virtual platform.
Safe and sustainable blood in Africa requires multi-stakeholder, multi-pronged, and innovative approaches to impact lives across the continent.
The World Health Organization (WHO) states that the number of units of blood needed to sustain an adequate level of health equals 1 percent of a nation’s population – 10 units per 1000 people. Yet many African countries fall well short of the minimum goal.
The lack of infrastructure and equipment for the collection and processing of blood components is a key impediment to providing a sustainable blood supply.
Though blood and safe transfusion services are essential parts of any strong health system, the safety, sustainability, and adequacy of blood remains a major health challenge in many African countries.
“Today is about mobilizing action, as we convene the first-ever Coalition of Blood in Africa,” said Antoinette Gawin, President and Chief Executive Officer, Terumo Blood, and Cell Technologies.
“The coalition’s goal is to support the World Health Organization’s commitments [WHA63.12] and aligns with our global mission to serve more patients. Providing safe access to blood in Africa is one way to achieve this.”
The coalition brings together an unprecedented array of health experts, including public-sector research institutes, ministries of health, academia, not-for-profit research and development organizations, NGOs, international organizations, and funders all committed to finding solutions to address the challenges facing access to safe, sustainable blood in Africa.
“The scale of the challenge is clearly beyond the scope of a single organization and I am confident that the Coalition will facilitate a coordinated approach to address the challenges facing blood in Africa and find sustainable solutions,” says Gavin Evans, Executive Director, Global Blood Fund.
The launch of CoBA was convened by Terumo Blood and Cell Technologies, a global leader in blood component, therapeutic apheresis, and cell technology, in collaboration with Global Blood Fund, Africa Practice, Africa Health Business, and Siemens Healthineers.